Video abstract of original research paper "Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease" published in the International Journal of General Medicine by Raphael Stricker, Allison DeLong, Christine Green, et al.

Read the original research article here: http://www.dovepress.com/benefitofi...

Conclusion: Prolonged intravenous antibiotic therapy is associated with improved cognition, fatigue, and myalgias in patients referred for treatment of neurologic Lyme disease. Treatment for 2552 weeks may be necessary to obtain symptomatic improvement in these patients.